摘要
目的从文献计量的角度分析2019年12月以来新型冠状病毒肺炎(以下简称新冠肺炎)相关药学研究,旨在为科研工作者开展后续药学研究提供参考依据。方法在中国知网、中国生物医学文献数据库、万方数据库、维普数据库及PubMed上,分别检索2019年12月1日至2020年6月30日已发表或网络首发的新冠肺炎药学研究相关中文及英文文献,采用文献计量学方法进行统计和分析。结果最终纳入符合标准的567篇中文文献及190篇英文文献,分析结果显示文献来源和研究机构相对集中,主要研究热点包括中医药相关的药物治疗研究、疫情下的药学监护和药事管理等。结论我国在短时间内已有一定数量的新冠肺炎药学研究成果集中产出,下一步应基于患者药学问题丰富研究类型,深入研究内容,产出更多药学研究成果。
Objective To conduct bibliometric analysis on literatures related to corona virus disease 2019(COVID-19) since December 2019,and to provide reference for researchers conducting follow-up pharmacy related researches. Methods Literatures in Chinese related to COVID-19 published or pre-published from December 1,2019 to June 30,2020 were searched in databases including CNKI database,CBM database,Wanfang database,VIP database. Literatures in English were searched in PubMed database. Statistics and analysis were performed using bibliometric methods. Results A total of 567 literatures in Chinese and 190 literatures in English that met the standards were included. The journals and research institutes that published these papers were relatively concentrated. The main research hotspots included researches on drug discovery based on traditional Chinese medicine,pharmaceutical care and pharmacy administration. Conclusion In China,a certain number of COVID-19 pharmacy research results have been produced in a short period of time. The next step should be to enrich the research types based on pharmacy related problems,in-depth research content,and produce more research results.
作者
马登磊
张兰
MA Deng-lei;ZHANG Lan(Department of Pharmacy,Xuanwu Hospital Capital Medical University,Beijing 100053,China)
出处
《临床药物治疗杂志》
2020年第9期58-62,共5页
Clinical Medication Journal
基金
北京市首都科技领军人才培养工程(项目编号:Z191100006119017)
北京市医院管理中心“登峰”计划专项(项目编号:DFL2019-0803)
首都医科大学宣武医院“汇智”人才工程学者计划-培育计划(领军人才)。
